A drug with the SMILES CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)[C@H](O)[C@@H]1C[C@@H]1C(=O)N1CCCC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 23.028\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)[C@H](O)[C@@H]1C[C@@H]1C(=O)N1CCCC1
CC(C)(C)OC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)[C@H](O)[C@@H]1C[C@@H]1C(=O)N1CCCC1
tert-butyl (2S)-2-[[(1R,2S)-1,3-dihydroxy-1-[(1R,2S)-2-(pyrrolidine-1-carbonyl)cyclopropyl]propan-2-yl]carbamoyl]pyrrolidine-1-carboxylate